10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript February 15, 2024
10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.36. 10x Genomics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good afternoon. My name is Jeannie, and I will be your conference operator today. I would like to welcome you to the 10x Genomics Fourth Quarter And Full-Year...
